Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S5 from Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia
  1. Home
  2. Publications
  3. Figure S5 from Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia

Figure S5 from Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia

Authors:
  • Kazuharu Kamachi
    Kazuharu Kamachi
  • Hiroshi Ureshino
    Hiroshi Ureshino
  • Tatsuro Watanabe
    Tatsuro Watanabe
  • Nao Yoshida-Sakai
    Nao Yoshida-Sakai
  • YFYuki Fukuda-Kurahashi
    Yuki Fukuda-Kurahashi
  • KKKazunori Kawasoe
    Kazunori Kawasoe
  • THToshimi Hoshiko
    Toshimi Hoshiko
  • YYYuta Yamamoto
    Yuta Yamamoto
  • YKYuki Kurahashi
    Yuki Kurahashi
  • Shinya Kimura
    Shinya Kimura

Open Access
Publisher website
Google Scholar
  • 4 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2767-9764.22546524.v1
Abstract
Figure S5. The combination effect of venetoclax (Ven) and S63845 (S6) in acute myeloid leukemia.
Keywords
  • VENETOCLAX
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.